Holen Sie sich die Stockscreener-App
14.64
0.48%
-0.06
Schlusskurs vom Vortag:
$14.70
Offen:
$14.7
24-Stunden-Volumen:
197.37K
Relative Volume:
0.10
Marktkapitalisierung:
$1.44B
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-5.9755
EPS:
-2.45
Netto-Cashflow:
$-64.37M
1W Leistung:
+7.26%
1M Leistung:
+17.04%
6M Leistung:
+89.51%
1J Leistung:
+106.93%
1-Tages-Spanne:
$14.41
$14.79
1-Wochen-Bereich:
$13.06
$15.29
52-Wochen-Spanne:
$4.70
$15.29
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
14.61 | 1.45B | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.19 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.19 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-08-04 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-01-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-10-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-07-24 | Eingeleitet | ROTH MKM | Buy |
| 2024-05-29 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
| 2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Eingeleitet | ROTH Capital | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
Is Mind Medicine (MindMed) Inc. stock oversold or undervaluedQuarterly Growth Report & Verified Entry Point Detection - ulpravda.ru
What makes Mind Medicine (MindMed) Inc. (MMQ) stock appealing to growth investors2025 Volume Leaders & Daily Profit Maximizing Trade Tips - ulpravda.ru
How strong dollar benefits Mind Medicine (MindMed) Inc. (MMQ) stockTrade Volume Summary & Pattern Based Trade Signal System - ulpravda.ru
Stock Recap: Can Mind Medicine (MindMed) Inc. stock deliver surprise earnings beat2025 Price Targets & Long Hold Capital Preservation Plans - ulpravda.ru
Mind Medicine stock hits 52-week high at $14.46 By Investing.com - Investing.com Nigeria
Assessing Mind Medicine (MNMD) Valuation After A Strong Year Of Share Price Momentum - Yahoo Finance
Mind Medicine (MindMed) (NASDAQ:MNMD) Sets New 52-Week HighStill a Buy? - MarketBeat
Mind Medicine stock hits 52-week high at $14.46 - Investing.com
MindMed stock added to Needham’s Conviction List, analyst reiterates Hold - Investing.com
Mind Medicine (MNMD) Projected to Shine in 2026 with Promising D - GuruFocus
The Technical Signals Behind (MNMD) That Institutions Follow - Stock Traders Daily
Is Mind Medicine MindMed Inc a good long term investmentTrendline Breakouts & Low Cost Portfolio Growth - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT) and Mind Medicine (MNMD) - The Globe and Mail
MindMed stock added to Needham’s Conviction List, analyst reiterates Hold By Investing.com - Investing.com Nigeria
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.8% on Insider Selling - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Daniel Karlin Sells 5,600 Shares - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Mark Sullivan Sells 11,276 Shares - MarketBeat
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Finviz
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 3.1%Should You Buy? - MarketBeat
Will Mind Medicine (MindMed) Inc. (MMQ) stock sustain uptrend momentumFundamental Stock Analysis & Minimal Investment Trading Plans - bollywoodhelpline.com
What’s driving JonesTrading’s bullish view on Mind Medicine (MindMed) Inc. (MNMD) - MSN
Aug Momentum: Is Mind Medicine MindMed Inc stock a safe investment in uncertain markets2025 Risk Factors & Verified Short-Term Plans - moha.gov.vn
What's Driving JonesTrading's Bullish View on Mind Medicine (MindMed) Inc. (MNMD) - Finviz
What’s Driving JonesTrading’s Bullish View on Mind Medicine (MindMed) Inc. (MNMD) - Insider Monkey
MindMed Expands Into Autism: What Investors Should Know About the New MM402 Trial - TipRanks
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from Analysts - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is MindMed (MNMD) Turning Psychedelic Policy Tailwinds Into a Durable Neuropsychiatry Advantage? - Sahm
Wall Street Thinks This 1 Psychedelic Stock Can Gain 335% in 2026 - Yahoo Finance
Trading Systems Reacting to (MNMD) Volatility - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 4.3%Here's What Happened - MarketBeat
Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? - Stocktwits
Jones Trading Initiates Coverage of Mind Medicine (MNMD) with Buy Recommendation - Nasdaq
Jones Trading initiates coverage of Mind Medicine (MNMD) with buy recommendation - MSN
Jones Trading Initiates Coverage on Mind Medicine (MNMD) with 'B - GuruFocus
Jones Trading initiates coverage on MindMed stock with Buy rating By Investing.com - Investing.com South Africa
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpTime to Buy? - MarketBeat
MindMed a new buy at Jones on promise of psychedelics for mental illnesses - Seeking Alpha
Jones Trading Begins Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Jones Trading initiates coverage on MindMed stock with Buy rating - Investing.com
Mind Medicine (MNMD) Receives a Rating Update from a Top Analyst - The Globe and Mail
Mind Medicine Inc Stock Intrinsic Values - GuruFocus
Mind Medicine (FRA:MMQ) EV-to-OCF : -9.03 (As of Dec. 21, 2025) - GuruFocus
New Highs: Will Mind Medicine (MindMed) Inc. (MMQ) stock sustain uptrend momentumJuly 2025 Setups & Verified Entry Point Detection - Улправда
How Mind Medicine (MindMed) Inc. stock benefits from tech adoptionWeekly Trend Report & Technical Pattern Based Signals - Улправда
Psychedelics stocks could benefit from marijuana rescheduling: Jefferies - Seeking Alpha
Can Mind Medicine (MindMed) Inc. stock surprise with earnings upsideQuarterly Performance Summary & High Win Rate Trade Tips - DonanımHaber
Assessing Mind Medicine (MNMD)’s Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance
Nasdaq Moves: What makes Mind Medicine (MindMed) Inc. stock attractive to growth fundsJuly 2025 Trends & Long-Term Growth Stock Strategies - moha.gov.vn
Assessing Mind Medicine (MNMD)’s Valuation After a Strong Recent Share Price Rally - Sahm
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mind Medicine Inc-Aktie (MNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer |
Dec 26 '25 |
Sale |
13.15 |
25,791 |
339,072 |
778,477 |
| Sullivan Mark | Chief Legal Officer |
Dec 26 '25 |
Sale |
13.15 |
11,276 |
148,244 |
282,576 |
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):